Ann: FY16 R&D Update, page-19

Lantana,
I do feel strongly that this is a genuine question to be asked ... and answered.
Its definitely not scaremongering as some would be quick to use to squash the validity of the question.

The Jaws clean out and subsequent delay in finding out a result for Jaws has caused contributed to this problem
Then you have$6m R&D you didn't expect had to be repaid.
Then you had the shortfall in the retail CR offer.

Its nobodies fault per say, All up STX Mgt have en counted a barrage of negative events which have resulted in this cash flow squeeze.

SH's have a right to know how the GOING CONCERN issues are being addressed, either by;
1. A firm renegotiation of payment time frame with CBA or
2. What is being worked on to generate cash. Farm in or CR or top 30 rights issue

If its a CR at 5.5c ....... that is the easy way and stinks of nepotism.

Either way ... its a serious discussion that needs to be had amongst all us peoples on HC.
Lets hear your thoughts and concerns !!!